Department of Neural and Pain Sciences, School of Dentistry, University of Maryland, Baltimore, MD, USA.
Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Mol Pain. 2021 Jan-Dec;17:1744806921997206. doi: 10.1177/1744806921997206.
Beta 2 adrenergic receptor (β2 AR) activation in the central and peripheral nervous system has been implicated in nociceptive processing in acute and chronic pain settings with anti-inflammatory and anti-allodynic effects of β2-AR mimetics reported in several pain states. In the current study, we examined the therapeutic efficacy of the β2-AR agonist clenbuterol in a rat model of persistent postsurgical hypersensitivity induced by disruption of descending noradrenergic signaling in rats with plantar incision. We used growth curve modeling of ipsilateral mechanical paw withdrawal thresholds following incision to examine effects of treatment on postoperative trajectories. Depletion of spinal noradrenergic neurons delayed recovery of hypersensitivity following incision evident as a flattened slope compared to non-depleted rats (-1.8 g/day with 95% CI -2.4 to -1.085, p < 0.0001). Chronic administration of clenbuterol reduced mechanical hypersensitivity evident as a greater initial intercept in noradrenergic depleted (6.2 g with 95% CI 1.6 to 10.8, p = 0.013) and non-depleted rats (5.4 g with 95% CI 1.2 to 9.6, p = 0.018) with plantar incision compared to vehicle treated rats. Despite a persistent reduction in mechanical hypersensitivity, clenbuterol did not alter the slope of recovery when modeled over several days (p = 0.053) or five weeks in depleted rats (p = 0.64). Systemic clenbuterol suppressed the enhanced microglial activation in depleted rats and reduced the density of macrophage at the site of incision. Direct spinal infusion of clenbuterol failed to reduce mechanical hypersensitivity in depleted rats with incision suggesting that beneficial effects of β2-AR stimulation in this model are largely peripherally mediated. Lastly, we examined β2-AR distribution in the spinal cord and skin using hybridization and IHC. These data add to our understanding of the role of β2-ARs in the nervous system on hypersensitivity after surgical incision and extend previously observed anti-inflammatory actions of β2-AR agonists to models of surgical injury.
β2 肾上腺素能受体 (β2AR) 在中枢和外周神经系统中的激活被认为与急性和慢性疼痛环境中的伤害感受处理有关,并且β2AR 激动剂模拟物在几种疼痛状态下具有抗炎和抗痛觉过敏的作用。在目前的研究中,我们在通过破坏足底切口大鼠的下行去甲肾上腺素能信号而诱导的持续性手术后超敏反应的大鼠模型中检查了β2-AR 激动剂克仑特罗的治疗效果。我们使用切口后同侧机械性爪撤回阈值的生长曲线建模来检查治疗对术后轨迹的影响。与非耗竭大鼠相比,脊髓去甲肾上腺素能神经元耗竭延迟了切口后超敏反应的恢复,表现为斜率变平(-1.8 g/天,95%置信区间为-2.4 至-1.085,p < 0.0001)。克仑特罗的慢性给药减轻了机械性超敏反应,表现为去甲肾上腺素能耗竭大鼠(6.2 g,95%置信区间为 1.6 至 10.8,p = 0.013)和非耗竭大鼠(5.4 g,95%置信区间为 1.2 至 9.6,p = 0.018)与载体处理的大鼠相比,切口处的初始截距更大。尽管机械性超敏反应持续减轻,但当在数天内(p = 0.053)或在耗竭大鼠中建模 5 周时(p = 0.64),克仑特罗并未改变恢复的斜率。系统给予克仑特罗可抑制耗竭大鼠中增强的小胶质细胞激活,并减少切口部位的巨噬细胞密度。直接向脊髓输注克仑特罗未能减轻耗竭大鼠的机械性超敏反应,这表明该模型中β2-AR 刺激的有益作用主要是外周介导的。最后,我们使用杂交和免疫组化检查了脊髓和皮肤中的β2-AR 分布。这些数据增加了我们对手术后手术切口引起的超敏反应中β2-AR 在神经系统中的作用的理解,并将β2-AR 激动剂的先前观察到的抗炎作用扩展到手术损伤模型。